{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:06:48Z","timestamp":1783933608925,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["2\/100\/44"],"award-info":[{"award-number":["2\/100\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2024.e24581","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T04:49:34Z","timestamp":1704948574000},"page":"e24581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of ubiquitin specific Peptidase-18 gene in peripheral blood of chronic hepatitis C patients treated with direct-acting antiviral drugs"],"prefix":"10.1016","volume":"10","author":[{"given":"Sami","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Rafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-9689","authenticated-orcid":false,"given":"Muhammad","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-4493","authenticated-orcid":false,"given":"Jalal","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-6080","authenticated-orcid":false,"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e24581_bib1","series-title":"Impact of Hepatitis C Virus (HCV) Infection and Treatment on Mortality in the Country of Georgia, 2015\u20132020","author":"Gvinjilia","year":"2023"},{"key":"10.1016\/j.heliyon.2024.e24581_bib2","series-title":"Management of Hepatitis C: January 1989 through January 1997: 2200 Citations","author":"Gordner","year":"1997"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24581_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1478-3231.2011.02684.x","article-title":"An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region","volume":"32","author":"Nakano","year":"2012","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24581_bib4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24581_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2334-8-69","article-title":"Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission","volume":"8","author":"Idrees","year":"2008","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24581_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/1743-422X-8-466","article-title":"Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan","volume":"8","author":"Ali","year":"2011","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24581_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/08977190400000833","article-title":"Mini ReviewHuman interferons alpha, beta and omega","volume":"22","author":"Bekisz","year":"2004","journal-title":"Growth Factors"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24581_bib8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/jhep.2002.32672","article-title":"Mechanism of action of ribavirin in the combination treatment of chronic HCV infection","volume":"35","author":"Lau","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e24581_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1478-3231.2010.02411.x","article-title":"New direct\u2010acting antivirals' combination for the treatment of chronic hepatitis C","volume":"31","author":"Asselah","year":"2011","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24581_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/cid\/ciu012","article-title":"Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries","volume":"58","author":"Hill","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e24581_bib11","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e24581_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.326","article-title":"Multiple functions of USP18","volume":"7","author":"Honke","year":"2016","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e24581_bib13","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1039\/B907669G","article-title":"Dissection of USP catalytic domains reveals five common insertion points","volume":"5","author":"Ye","year":"2009","journal-title":"Mol. Biosyst."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e24581_bib14","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of Interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24581_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/gene.2014.17","article-title":"Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections","volume":"15","author":"Dauphinee","year":"2014","journal-title":"Gene Immun."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24581_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24581_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2006.08.043","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume":"131","author":"Randall","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24581_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022200","article-title":"USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon \u03b1 response","volume":"6","author":"Fran\u00e7ois-Newton","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24581_bib19","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1099\/jgv.0.000522","article-title":"IFN-\u03bb4 desensitizes the response to IFN-\u03b1 treatment in chronic hepatitis C through long-term induction of USP18","volume":"97","author":"Fan","year":"2016","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24581_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C T method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e24581_bib21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa1316145","article-title":"Sofosbuvir and ribavirin in HCV genotypes 2 and 3","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24581_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1053\/j.gastro.2015.07.043","article-title":"Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection","volume":"149","author":"Foster","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24581_bib23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.27726","article-title":"All\u2010oral 12\u2010week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY\u20103 phase III study","volume":"61","author":"Nelson","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24581_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006374","article-title":"Characterization of miR-122-independent propagation of HCV","volume":"13","author":"Ono","year":"2017","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24581_bib25","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"Meissner","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e24581_bib26","first-page":"1853","article-title":"USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study","volume":"11","author":"Frankova","year":"2015","journal-title":"Therapeut. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24581_bib27","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180250","article-title":"USP18\u2013a multifunctional component in the interferon response","volume":"38","author":"Basters","year":"2018","journal-title":"Biosci. Rep."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e24581_bib28","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of Interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"Embo j"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e24581_bib29","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24581_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jvh.12510","article-title":"Achieving sustained virologic response after interferon\u2010free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis","volume":"23","author":"Meissner","year":"2016","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24581_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47553-2","article-title":"Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells","volume":"9","author":"Minafra","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24581_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3851\/IMP3120","article-title":"Effect of minor populations of NS5A and NS5B resistance-associated variants on HCV genotype-3 response to daclatasvir plus sofosbuvir, with or without ribavirin","volume":"22","author":"McPhee","year":"2017","journal-title":"Antivir. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24581_bib33","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and non-responders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24581_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3855\/jidc.1169","article-title":"Of lives and livers: emerging responses to the hepatitis C virus","volume":"5","author":"Noorali","year":"2011","journal-title":"The Journal of Infection in Developing Countries"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24581_bib35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4236\/abb.2013.49115","article-title":"Estimation of HCV viral load and liver enzymes among different patients groups of District Gujrat, Pakistan","volume":"4","author":"Mushtaq","year":"2013","journal-title":"Adv. Biosci. Biotechnol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24581_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00042737-200409000-00013","article-title":"Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression","volume":"16","author":"Zechini","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e24581_bib37","first-page":"502","article-title":"Relationship of liver enzymes with viral load of hepatitis C in HCV infected patients by data analytics (data analytics of HCV and liver profile)","volume":"9","author":"Ahmad","year":"2018","journal-title":"Int. J. Adv. Comput. Sci. Appl."},{"issue":"28","key":"10.1016\/j.heliyon.2024.e24581_bib38","doi-asserted-by":"crossref","first-page":"25377","DOI":"10.1074\/jbc.M111.222760","article-title":"Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7","volume":"286","author":"Duex","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024006121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024006121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:24:19Z","timestamp":1783931059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024006121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844024006121"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24581","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of ubiquitin specific Peptidase-18 gene in peripheral blood of chronic hepatitis C patients treated with direct-acting antiviral drugs","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24581"}}